Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype**

ChemMedChem(2022)10.1002/cmdc.202200161Source: DataRank Database

Identification of 4‐Anilinoquin(az)oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype** is a research paper published in ChemMedChem (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.25)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Louisa Temme ORCID,Michael P. East ORCID,Tuomo Laitinen ORCID,Julie E. Pickett ORCID,Frank E. Kwarcinski

Live enrichment

PubMed:35403825 PMC:PMC9233141 OpenAlex:https://openalex.org/W4223528634

Canada Foundation for Innovation

Grant: 1097737

Innovative Medicines Initiative

Grant: 115766

Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery

National Institutes of Health

Grant: 1U24DK116204-01

Illuminating Function of the Understudied Druggable Kinome

University of North Carolina at Chapel Hill

Grant: CHE-1726291

NIDDK NIH HHS

Grant: U24 DK116204

Wellcome Trust

Grant: 106169/ZZ14/Z

NCATS NIH HHS

Grant: R44 TR001916

National Institutes of Health

Grant: 1R44TR001916-01

Tools for Accelerating R&D for Historically Understudied Protein Kinases

Wellcome Trust

Grant: 106169

A UK Hub to Catalyse Open Target Discovery.

National Science Foundation

Grant: 1726291

MRI: Acquisition of a Mass Spectrometer

FWCI

0.25

Citation Percentile

0.5%

Citation Trend

2022

2023

2025

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9233141

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200161

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cmdc.202200161

publisherhttps://chemistry-europe.onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200161

Fields of Study

Protein Kinase Regulation and GTPase SignalingClick Chemistry and ApplicationsCancer Mechanisms and Therapy0301 basic medicine0303 health sciences03 medical and health sciencesHumansMaleProstatic NeoplasmsProtein Kinase CProtein Kinase Inhibitors

MeSH Terms

HumansMaleProstatic NeoplasmsProtein Kinase CProtein Kinase Inhibitors

Keywords

ChemotypeKinaseChemistryProtein kinase inhibitorIdentification (biology)Protein kinase ABiochemistryCancer researchBiologyComputational biologyHomology Model4-Anilinoquinazoline4-AnilinoquinolineProtein Kinase Novel 3 (Pkn3)MaleHumansProstatic NeoplasmsProtein Kinase InhibitorsProtein Kinase C

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being